{"abstract":"The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable, patent license to Georgetown University \"Georgetown\", a private university located in Washington DC, to its rights to the invention embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2022/04/13/2022-07866.html","cfr_references":[],"citation":"87 FR 21892","comment_url":null,"comments_close_on":"2022-04-28","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before April 28, 2022 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2022-07866","effective_on":null,"end_page":21893,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2022/04/13/2022-07866.xml","html_url":"https://www.federalregister.gov/documents/2022/04/13/2022-07866/prospective-grant-of-an-exclusive-patent-license-development-of-diagnostic-for-imaging-and-early","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2022-07866?publication_date=2022-04-13","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2022-04-13/2022-07866/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":134,"last_updated":"2026-07-28 16:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-04-13/pdf/2022-07866.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-07866.pdf?1649769151","publication_date":"2022-04-13","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2022/04/13/2022-07866.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T17:19:19Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":21892,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Development of Diagnostic for Imaging and Early Detection of Pancreatic Cancer and Pre-Cancerous Lesions by Targeting the Cholecystokinin-B Receptor","toc_doc":"Development of Diagnostic for Imaging and Early Detection of Pancreatic Cancer and Pre-Cancerous Lesions by Targeting the Cholecystokinin-B Receptor","toc_subject":"Licenses; Exemptions, Applications, Amendments, etc.","topics":[],"type":"Notice","volume":87}